Skip to content
Stop using now Drug recall · FDA · Published November 6, 2013

Sandoz Sumatriptan Recall: Sterility Risk Due to Protruding Needles

Sandoz recalls specific lots of Sumatriptan Succinate Injection because needles may protrude through shields, risking sterility. Check your lot number.

🇺🇸 FDA recall #D-388-2014DrugSandoz ›
Take action

Contact the company

Recalling firmGlaxoSmithKline, LLC.1011 North Arendell Ave · Zebulon, NC 27597-1217
✎ GovInfoNow plain-language explainer

Sandoz Inc. is recalling a small number of pre-filled syringes of Sumatriptan Succinate Injection (6 mg) because the needle shields may not fully cover the needles. This defect poses a risk that the contents are no longer sterile, which could lead to infection if injected. The recall affects 9,743 cartridges distributed nationwide. Read more at govinfonow.com/recall/46425-glaxosmithkline-llc-recalls-sumatriptan-succinate-injection-6-mg-0-5.

Source Summary by GovInfoNow · govinfonow.com/recall/46425-glaxosmithkline-llc-recalls-sumatriptan-succinate-injection-6-mg-0-5 · Updated October 13, 2026 · FDA enforcement record: FDA #D-388-2014

Cite this page

“Sandoz Sumatriptan Recall: Sterility Risk Due to Protruding Needles.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46425-glaxosmithkline-llc-recalls-sumatriptan-succinate-injection-6-mg-0-5. Based on FDA recall #D-388-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-388-2014%22&limit=1).

The FDA announced on 2013-11-06 that GlaxoSmithKline LLC voluntarily recalled Sandoz Sumatriptan Succinate Injection due to a lack of assurance of sterility. The hazard involves pre-filled syringes with needles protruding through the needle shield.

How to tell if you have it

  • Brand: Sandoz
  • Product: Sumatriptan Succinate Injection, 6 mg, 0.5 mL
  • NDC: 0781-3173-07
  • Lot#: C636242
  • Expiration: 06/15

The hazard

A small number of pre-filled syringes may contain needles which protrude through the needle shield, creating a lack of assurance of sterility.

Context

GovInfoNow's records show GlaxoSmithKline LLC has 11 other recalls on record since 2012-10-08. Other recent recalls include labeling errors for Tivicay PD (2024-05-17) and Tivicay Tablets (2022-05-13), as well as failed release testing for ANORO ELLIPTA inhalers (2023-12-12). Similar products recalled recently include Reliance Bortezomib Injection (2026-06-24) and New Life Pharma Semaglutide Injections (2026-02-26), both citing lack of sterility assurance.

How to tell if you have this one

Check your package for NDC 0781-3173-07 and Lot number C636242 with an expiration date of 06/15. The product is labeled as Sumatriptan Succinate Injection, 6 mg, 0.5 mL, manufactured by GlaxoSmithKline for Sandoz Inc.

  • Brand
    Sandoz
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide
Recall numberProduct, codes & lotsQuantityNDC
D-387-2014Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each containing 6 mg of sumatriptan for subcutaneous injection only, 1 imitrex STATdose Pen, 1 carrying case, Rx only, 6 mg, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in Singapore, NDC 0173-0479-00; Lot#: C636293, Exp: 06/1510,469 Systems0173-0739-00, 0173-0739-02, 0173-0479-00, 0173-0478-00
D-388-2014Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.; Lot#: C636242, Exp: 06/159,743 cartridges—
Based on the official FDA remedy

What to do — step by step

  1. Stop using the medication

    Do not use any syringes that match the recalled lot number C636242 due to the risk of non-sterile contents.

  2. Contact your healthcare provider

    Reach out to your doctor or pharmacist immediately to discuss alternative treatments for your condition.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Nov 6, 201312. FDA classified it Class II: Dec 24, 201323. Published in FDA’s Enforcement Report: Jan 1, 201434. FDA terminated the recall: Aug 20, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Who is manufacturing this product?

The product is manufactured by GlaxoSmithKline LLC in Research Triangle Park, NC, for Sandoz Inc. in Princeton, NJ.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-388-2014 (November 6, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-388-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA